VectorY Secures New Financing for Vectorized Antibodies

VectorY announced November 11 €74.5 million in new financing for its clinical and preclinical neurodegeneration pipeline. Investor disclosures independently confirm €30 million of the amount as a European Investment Bank convertible loan and €7…




